ITGB1 overexpression has been observed in many human malignancies, including lung, breast, and colorectal cancers, significantly impacting metastasis and patient survival.[42, 43] Consistent with these data, we observed a significant correlation of ITGB1 expression with chordoma characteristics and patient outcomes. The gene discussed is ITGB1; the disease is colorectal cancer.